KERALA AYURVEDA
Back to Balance Sheet
|
KERALA AYURVEDA Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹88 Cr | ₹40 Cr | ₹53 Cr | ₹60 Cr | ₹42 Cr |
What is the latest Total Current Liabilities ratio of KERALA AYURVEDA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹88 Cr |
| Mar2024 | ₹40 Cr |
| Mar2023 | ₹53 Cr |
| Mar2022 | ₹60 Cr |
| Mar2021 | ₹42 Cr |
How is Total Current Liabilities of KERALA AYURVEDA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹88 Cr | 117.74 | |
| Mar2024 | ₹40 Cr | -23.32 | |
| Mar2023 | ₹53 Cr | -12.60 | |
| Mar2022 | ₹60 Cr | 43.83 | |
| Mar2021 | ₹42 Cr | - | |
Compare Total Current Liabilities of peers of KERALA AYURVEDA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KERALA AYURVEDA | ₹231.4 Cr | -5.2% | -16.2% | -59% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,933.0 Cr | -0.7% | -3.6% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,833.0 Cr | 1.1% | -1.2% | -0.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,549.0 Cr | 1.6% | 1.4% | 36.7% | Stock Analytics | |
| CIPLA | ₹113,155.0 Cr | 0.7% | 2.6% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,654.0 Cr | -0.9% | -2.5% | 1.2% | Stock Analytics | |
KERALA AYURVEDA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KERALA AYURVEDA | -5.2% |
-16.2% |
-59% |
| SENSEX | -0.7% |
-3.6% |
-9.1% |
You may also like the below Video Courses